36570536|t|Modulations of bioactive lipids and their receptors in postmortem Alzheimer's disease brains.
36570536|a|Background: Analyses of brain samples from Alzheimer's disease (AD) patients may be expected to help us improve our understanding of the pathogenesis of AD. Bioactive lipids, including sphingolipids, glycerophospholipids, and eicosanoids/related mediators have been demonstrated to exert potent physiological actions and to be involved in the pathogenesis of various human diseases. In this cross-sectional study, we attempted to elucidate the associations of these bioactive lipids with the pathogenesis/pathology of AD through postmortem studies of human brains. Methods: We measured the levels of glycerophospholipids, sphingolipids, and eicosanoids/related mediators in the brains of patients with AD (AD brains), patients with Cerad score B (Cerad-b brains), and control subjects (control brains), using a liquid chromatography-mass spectrometry method; we also measured the mRNA levels of specific receptors for these bioactive lipids in the same brain specimens. Results: The levels of several species of sphingomyelins and ceramides were higher in the Cerad-b and AD brains. Levels of several species of lysophosphatidic acids (LPAs), lysophosphatidylcholine, lysophosphatidylserine, lysophosphatidylethanolamine (LPE), lysophosphatidylinositol, phosphatidylcholine, phosphatidylserine (PS), phosphatidylethanolamine (PE), phosphatidylinositol, and phosphatidylglycerol were especially high in the Cerad-b brains, while those of lysophosphatidylglycerol (LPG) were especially high in the AD brains. Several eicosanoids, including metabolites of prostaglandin E2, oxylipins, metabolites of epoxide, and metabolites of DHA and EPA, such as resolvins, were also modulated in the AD brains. Among the lipid mediators, the levels of S1P2, S1P5, LPA1, LPA2, LPA6, P2Y10, GPR174, EP1, DP1, DP2, IP, FP, and TXA2r were lower in the AD and/or Cerad-b brains. The brain levels of ceramides, LPC, LPI, PE, and PS showed strong positive correlations with the Abeta contents, while those of LPG showed rather strong positive correlations with the presence of senile plaques and neurofibrillary tangles. A discriminant analysis revealed that LPG is especially important for AD and the LPE/PE axis is important for Cerad-b. Conclusions: Comprehensive lipidomics, together with the measurement of lipid receptor expression levels provided novel evidence for the associations of bioactive lipids with AD, which is expected to facilitate future translational research and reverse translational research.
36570536	25	31	lipids	Chemical	MESH:D008055
36570536	66	85	Alzheimer's disease	Disease	MESH:D000544
36570536	137	156	Alzheimer's disease	Disease	MESH:D000544
36570536	158	160	AD	Disease	MESH:D000544
36570536	162	170	patients	Species	9606
36570536	247	249	AD	Disease	MESH:D000544
36570536	261	267	lipids	Chemical	MESH:D008055
36570536	279	292	sphingolipids	Chemical	MESH:D013107
36570536	294	314	glycerophospholipids	Chemical	MESH:D020404
36570536	320	331	eicosanoids	Chemical	MESH:D015777
36570536	461	466	human	Species	9606
36570536	570	576	lipids	Chemical	MESH:D008055
36570536	612	614	AD	Disease	MESH:D000544
36570536	645	650	human	Species	9606
36570536	694	714	glycerophospholipids	Chemical	MESH:D020404
36570536	716	729	sphingolipids	Chemical	MESH:D013107
36570536	735	746	eicosanoids	Chemical	MESH:D015777
36570536	782	790	patients	Species	9606
36570536	796	798	AD	Disease	MESH:D000544
36570536	800	802	AD	Disease	MESH:D000544
36570536	812	820	patients	Species	9606
36570536	1028	1034	lipids	Chemical	MESH:D008055
36570536	1106	1120	sphingomyelins	Chemical	MESH:D013109
36570536	1125	1134	ceramides	Chemical	MESH:D002518
36570536	1166	1168	AD	Disease	MESH:D000544
36570536	1206	1228	lysophosphatidic acids	Chemical	MESH:D008246
36570536	1230	1234	LPAs	Chemical	MESH:D008246
36570536	1237	1260	lysophosphatidylcholine	Chemical	MESH:D008244
36570536	1262	1284	lysophosphatidylserine	Chemical	MESH:C025059
36570536	1286	1314	lysophosphatidylethanolamine	Chemical	MESH:C008301
36570536	1316	1319	LPE	Chemical	MESH:C008301
36570536	1322	1346	lysophosphatidylinositol	Chemical	MESH:C025449
36570536	1348	1367	phosphatidylcholine	Chemical	MESH:D010713
36570536	1369	1387	phosphatidylserine	Chemical	MESH:D010718
36570536	1389	1391	PS	Chemical	MESH:D010718
36570536	1394	1418	phosphatidylethanolamine	Chemical	MESH:C483858
36570536	1420	1422	PE	Chemical	MESH:C483858
36570536	1425	1445	phosphatidylinositol	Chemical	MESH:D010716
36570536	1451	1471	phosphatidylglycerol	Chemical	MESH:D010715
36570536	1531	1555	lysophosphatidylglycerol	Chemical	MESH:C026223
36570536	1557	1560	LPG	Chemical	MESH:C026223
36570536	1590	1592	AD	Disease	MESH:D000544
36570536	1609	1620	eicosanoids	Chemical	MESH:D015777
36570536	1647	1663	prostaglandin E2	Chemical	MESH:D015232
36570536	1665	1674	oxylipins	Chemical	MESH:D054883
36570536	1691	1698	epoxide	Chemical	MESH:D004852
36570536	1719	1722	DHA	Chemical	MESH:C027493
36570536	1740	1749	resolvins	Chemical	-
36570536	1778	1780	AD	Disease	MESH:D000544
36570536	1799	1804	lipid	Chemical	MESH:D008055
36570536	1830	1834	S1P2	Gene	9294
36570536	1836	1840	S1P5	Gene	53637
36570536	1842	1846	LPA1	Gene	1902
36570536	1848	1852	LPA2	Gene	9170
36570536	1854	1858	LPA6	Gene	10161
36570536	1860	1865	P2Y10	Gene	27334
36570536	1867	1873	GPR174	Gene	84636
36570536	1875	1878	EP1	Gene	5731
36570536	1880	1883	DP1	Gene	5729
36570536	1885	1888	DP2	Gene	7029
36570536	1890	1892	IP	Chemical	MESH:C041508
36570536	1902	1907	TXA2r	Gene	6915
36570536	1926	1928	AD	Disease	MESH:D000544
36570536	1972	1981	ceramides	Chemical	MESH:D002518
36570536	1983	1986	LPC	Chemical	-
36570536	1993	1995	PE	Chemical	MESH:C483858
36570536	2001	2003	PS	Chemical	MESH:D010718
36570536	2049	2054	Abeta	Gene	351
36570536	2080	2083	LPG	Chemical	MESH:C026223
36570536	2167	2190	neurofibrillary tangles	Disease	MESH:D055956
36570536	2230	2233	LPG	Chemical	MESH:C026223
36570536	2262	2264	AD	Disease	MESH:D000544
36570536	2273	2276	LPE	Chemical	MESH:C008301
36570536	2277	2279	PE	Chemical	MESH:C483858
36570536	2474	2480	lipids	Chemical	MESH:D008055
36570536	2486	2488	AD	Disease	MESH:D000544
36570536	Association	MESH:D000544	53637
36570536	Association	MESH:C025059	MESH:D000544
36570536	Association	MESH:D000544	1902
36570536	Association	MESH:C483858	MESH:D000544
36570536	Association	MESH:D010713	MESH:D000544
36570536	Association	MESH:D000544	27334
36570536	Association	MESH:D054883	MESH:D000544
36570536	Association	MESH:D000544	7029
36570536	Association	MESH:D008055	MESH:D000544
36570536	Association	MESH:D000544	9170
36570536	Association	MESH:D000544	5731
36570536	Association	MESH:D010715	MESH:D000544
36570536	Association	MESH:D000544	10161
36570536	Association	MESH:D015777	MESH:D000544
36570536	Association	MESH:D000544	84636
36570536	Association	MESH:C027493	MESH:D000544
36570536	Association	MESH:D008244	MESH:D000544
36570536	Association	MESH:D010718	351
36570536	Association	MESH:D002518	351
36570536	Positive_Correlation	MESH:D013109	MESH:D000544
36570536	Association	MESH:D010716	MESH:D000544
36570536	Association	MESH:C025449	MESH:D000544
36570536	Positive_Correlation	MESH:C026223	MESH:D055956
36570536	Association	MESH:C008301	MESH:D000544
36570536	Association	MESH:D000544	6915
36570536	Association	MESH:D000544	5729
36570536	Positive_Correlation	MESH:C026223	MESH:D000544
36570536	Association	MESH:C483858	351
36570536	Association	MESH:D010718	MESH:D000544
36570536	Positive_Correlation	MESH:D002518	MESH:D000544
36570536	Association	MESH:D000544	351
36570536	Association	MESH:D008246	MESH:D000544
36570536	Association	MESH:D000544	9294
36570536	Association	MESH:D015232	MESH:D000544

